Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interleukin-17--extended features of a key player in multiple sclerosis.

Literature DB >> 18063700

Interleukin-17--extended features of a key player in multiple sclerosis.

Ralf Gold¹, Fred Lühder.

Abstract

Entities: Disease

Mesh：

Substances：
Cytokines
Interleukin-17

Year: 2007 PMID： 18063700 PMCID： PMC2189626 DOI： 10.2353/ajpath.2008.070862

Source DB: PubMed Journal: Am J Pathol ISSN： 0002-9440 Impact factor: 4.307

× No keyword cloud information.

29 in total

1. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.

Authors: Anne Brüstle; Sylvia Heink; Magdalena Huber; Christine Rosenplänter; Christine Stadelmann; Philipp Yu; Enrico Arpaia; Tak W Mak; Thomas Kamradt; Michael Lohoff
Journal: Nat Immunol Date: 2007-08-05 Impact factor: 25.606

2. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.

Authors: Eva V Acosta-Rodriguez; Giorgio Napolitani; Antonio Lanzavecchia; Federica Sallusto
Journal: Nat Immunol Date: 2007-08-05 Impact factor: 25.606

Review 3. Differentiation and function of Th17 T cells.

Authors: Brigitta Stockinger; Marc Veldhoen
Journal: Curr Opin Immunol Date: 2007-04-12 Impact factor: 7.486

4. The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells.

Authors: Harald H Hofstetter; Catharina Grau; Mathias Buttmann; Thomas G Forsthuber; Stefanie Gaupp; Klaus V Toyka; Ralf Gold
Journal: Cytokine Date: 2007-09-18 Impact factor: 3.861

Review 5. Immune deviation--the third dimension of nondeletional T cell tolerance.

Authors: M Röcken; E M Shevach
Journal: Immunol Rev Date: 1996-02 Impact factor: 12.988

Review 6. Interleukin-17 family members and inflammation.

Authors: Jay K Kolls; Anders Lindén
Journal: Immunity Date: 2004-10 Impact factor: 31.745

7. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.

Authors: Thomas Korn; Estelle Bettelli; Wenda Gao; Amit Awasthi; Anneli Jäger; Terry B Strom; Mohamed Oukka; Vijay K Kuchroo
Journal: Nature Date: 2007-06-20 Impact factor: 49.962

8. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.

Authors: Christian Skulina; Stephan Schmidt; Klaus Dornmair; Holger Babbe; Axel Roers; Klaus Rajewsky; Hartmut Wekerle; Reinhard Hohlfeld; Norbert Goebels
Journal: Proc Natl Acad Sci U S A Date: 2004-02-24 Impact factor: 11.205

9. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.

Authors: John S Tzartos; Manuel A Friese; Matthew J Craner; Jackie Palace; Jia Newcombe; Margaret M Esiri; Lars Fugger
Journal: Am J Pathol Date: 2007-12-21 Impact factor: 4.307

10. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Authors: Vissia Viglietta; Clare Baecher-Allan; Howard L Weiner; David A Hafler
Journal: J Exp Med Date: 2004-04-05 Impact factor: 14.307

12 in total

Review 1. The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.

Authors: Ahmad Reza Dorosty-Motlagh; Niyaz Mohammadzadeh Honarvar; Mohsen Sedighiyan; Mina Abdolahi
Journal: J Mol Neurosci Date: 2016-06-29 Impact factor: 3.444

Review 2. Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration.

Authors: Chi-Chao Chan; Daniel Ardeljan
Journal: Adv Exp Med Biol Date: 2014 Impact factor: 2.622

3. Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.

Authors: Mohammad-Reza Javan; Narges Seyfizadeh; Saeed Aslani; Mehdi Farhoodi; Zohreh Babaloo
Journal: Am J Clin Exp Immunol Date: 2014-08-15

4. Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?

Authors: Nicholas E Martinez; Fumitaka Sato; Seiichi Omura; Alireza Minagar; J Steven Alexander; Ikuo Tsunoda
Journal: Pathophysiology Date: 2012-05-26

5. Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model.

Authors: Hong Zhao; Paul Kiptoo; Todd D Williams; Teruna J Siahaan; Elizabeth M Topp
Journal: J Control Release Date: 2009-09-12 Impact factor: 9.776

6. The effects of transplanted mesenchymal stem cells treated with 17-b estradiol on experimental autoimmune encephalomyelitis.

Authors: Rahim Heidari Barchi Nezhad; Fateme Asadi; Seyyed Meysam Abtahi Froushani; Gholamhossein Hassanshahi; Ayat Kaeidi; Soudeh Khanamani Falahati-Pour; Zahra Hashemi; Mohammad Reza Mirzaei
Journal: Mol Biol Rep Date: 2019-09-25 Impact factor: 2.316

7. Host and Environmental Factors Influencing Individual Human Cytokine Responses.

Authors: Rob Ter Horst; Martin Jaeger; Sanne P Smeekens; Marije Oosting; Morris A Swertz; Yang Li; Vinod Kumar; Dimitri A Diavatopoulos; Anne F M Jansen; Heidi Lemmers; Helga Toenhake-Dijkstra; Antonius E van Herwaarden; Matthijs Janssen; Renate G van der Molen; Irma Joosten; Fred C G J Sweep; Johannes W Smit; Romana T Netea-Maier; Mieke M J F Koenders; Ramnik J Xavier; Jos W M van der Meer; Charles A Dinarello; Norman Pavelka; Cisca Wijmenga; Richard A Notebaart; Leo A B Joosten; Mihai G Netea
Journal: Cell Date: 2016-11-03 Impact factor: 41.582